oral glp 1 medications What You Need to Know About the New GLP-1 A new oral GLP-1 medication

TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions

As of December 2020, Saxenda is FDA-approved for use as a chronic weight management aid in adults and children over 12 years of age

Swab every stopper, every time, with a fresh alcohol pad

J.BorcheltD